Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Muscle atrophy, a significant characteristic of congenital muscular dystrophy with laminin α2 chain deficiency (also known as MDC1A), occurs by a change in the normal balance between protein synthesis and protein degradation. The ubiquitin-proteasome system (UPS) plays a key role in protein degradation in skeletal muscle cells. In order to identify new targets for drug therapy against MDC1A, we have investigated whether increased proteasomal degradation is a feature of MDC1A. Using the generated dy(3K)/dy(3K) mutant mouse model of MDC1A, we studied the expression of members of the ubiquitin-proteasome pathway in laminin α2 chain-deficient muscle, and we treated dy(3K)/dy(3K) mice with the proteasome inhibitor MG-132. We show that members of the UPS are upregulated and that the global ubiquitination of proteins is raised in dystrophic limb muscles. Also, phosphorylation of Akt is diminished in diseased muscles. Importantly, proteasome inhibition significantly improves the dystrophic dy(3K)/dy(3K) phenotype. Specifically, treatment with MG-132 increases lifespan, enhances locomotive activity, enlarges muscle fiber diameter, reduces fibrosis, restores Akt phosphorylation and decreases apoptosis. These studies promote better understanding of the disease process in mice and could lead to a drug therapy for MDC1A patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Members of the ubiquitin-proteasome system are upregulated and the global ubiquitylation of proteins is increased in the muscles of dystrophic patients with laminin α2 chain deficiency.”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
In the citing paper
“Interestingly, proteasome inhibition using MG-132 significantly improved the dystrophic phenotype (Carmignac et al., 2011).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
In the citing paper
“the administration of MG-132 significantly improved the dystrophic phenotype (Carmignac et al., 2011).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., & Campbell, K. P. (1992) · Nature · doi:10.1038/355696a0 · Cited by 1,410
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974
Modulation of Akt kinase activity by binding to Hsp90
Sato, S., Fujita, N., & Tsuruo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170276797 · Cited by 967
The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal Muscle
Clarke, B. A., Drujan, D., Willis, M. S., Murphy, L. O., Corpina, R. A., Burova, E., Rakhilin, S. V., Stitt, T. N., Patterson, C., Latres, E., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.009 · Cited by 683
Patton, B. L., Miner, J. H., Chiu, A. Y., & Sanes, J. R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.6.1507 · Cited by 436
Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse
Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T., & Magyar, J. P. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.06.008 · Cited by 421
Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M., & Schiaffino, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142166599 · Cited by 402
Léger, B., Cartoni, R., Praz, M., Lamon, S., Dériaz, O., Crettenand, A., Gobelet, C., Rohmer, P., Konzelmann, M., Luthi, F., et al. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116715 · Cited by 381
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
Kedar, V., McDonough, H., Arya, R., Li, H.-H., Rockman, H. A., & Patterson, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404341102 · Cited by 347
Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle
Mammucari, C., Schiaffino, S., & Sandri, M. (2008) · Autophagy · doi:10.4161/auto.5905 · Cited by 295
Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K., Nabeshima, Y.-I., & Takeda, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01007-7 · Cited by 263
Song, W. K. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.3.643 · Cited by 238
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy
Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmüller, H., Engvall, E., Müller, U., & Ruegg, M. A. (2001) · Nature · doi:10.1038/35095054 · Cited by 238
Involvement of Hsp90 in Signaling and Stability of 3-Phosphoinositide-dependent Kinase-1
Fujita, N., Sato, S., Ishida, A., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106736200 · Cited by 198
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
Kuang, W., Xu, H., Vachon, P. H., Liu, L., Loechel, F., Wewer, U. M., & Engvall, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3705 · Cited by 188
von der Mark, H., Dürr, J., Sonnenberg, A., von der Mark, K., Deutzmann, R., & Goodman, S. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54324-6 · Cited by 160
Allamand, V., & Guicheney, P. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200743 · Cited by 150
Langenbach, K. J., & Rando, T. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10258 · Cited by 144
α7β1-Integrin regulates mechanotransduction and prevents skeletal muscle injury
Boppart, M. D., Burkin, D. J., & Kaufman, S. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2005 · Cited by 143
Bonuccelli, G., Sotgia, F., Schubert, W., Park, D. S., Frank, P. G., Woodman, S. E., Insabato, L., Cammer, M., Minetti, C., & Lisanti, M. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63523-7 · Cited by 135
Laminin 1 chain reduces muscular dystrophy in laminin 2 chain deficient mice
Gawlik, K. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh190 · Cited by 131
Ringelmann, B., Röder, C., Hallmann, R., Maley, M. A. L., Davies, M. J., Grounds, M. D., & Sorokin, L. M. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4244 · Cited by 124
Mechanisms of skeletal muscle atrophy
Ventadour, S., & Attaix, D. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000245731.25383.de · Cited by 122
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy
Girgenrath, M., Dominov, J. A., Kostek, C. A., & Boone Miller, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422928 · Cited by 119
Selective control of skeletal muscle differentiation by Akt1
Wilson, E. M., & Rotwein, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600315200 · Cited by 118
Omigapil Ameliorates the Pathology of Muscle Dystrophy Caused by Laminin-α2 Deficiency
Erb, M., Meinen, S., Barzaghi, P., Sumanovski, L. T., Courdier-Fruh, I., Rüegg, M. A., & Meier, T. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160754 · Cited by 93
Qiao, C., Li, J., Zhu, T., Draviam, R., Watkins, S., Ye, X., Chen, C., Li, J., & Xiao, X. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502137102 · Cited by 92
Pathology is alleviated by doxycycline in a laminin‐α2–null model of congenital muscular dystrophy
Girgenrath, M., Beermann, M. L., Vishnudas, V. K., Homma, S. T., & Miller, J. B. (2009) · Annals of Neurology · doi:10.1002/ana.21523 · Cited by 84
Meinen, S., Barzaghi, P., Lin, S., Lochmüller, H., & Rüegg, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611152 · Cited by 79
Bonuccelli, G., Sotgia, F., Capozza, F., Gazzerro, E., Minetti, C., & Lisanti, M. P. (2007) · Cell Cycle · doi:10.4161/cc.6.10.4182 · Cited by 75
Dominov, J. A., Kravetz, A. J., Ardelt, M., Kostek, C. A., Beermann, M. L., & Miller, J. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi095 · Cited by 74
Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling
Laure, L., Suel, L., Roudaut, C., Bourg, N., Ouali, A., Bartoli, M., Richard, I., & Danièle, N. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06814.x · Cited by 71
Laminin α1 chain improves laminin α2 chain deficient peripheral neuropathy
Gawlik, K. I., Li, J., Petersén, Å., & Durbeej, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl201 · Cited by 69
Self-citationAssereto, S., Stringara, S., Sotgia, F., Bonuccelli, G., Broccolini, A., Pedemonte, M., Traverso, M., Biancheri, R., Zara, F., Bruno, C., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00434.2005 · Cited by 65
Hayashi, Y. K., Težak, Ž., Momoi, T., Nonaka, I., García, C., Hoffman, E. P., & Arahata, K. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00203-0 · Cited by 62
Nakagawa, M., Miyagoe‐Suzuki, Y., Ikezoe, K., Miyata, Y., Nonaka, I., Harii, K., & Takeda, S. (2001) · Glia · doi:10.1002/glia.1075 · Cited by 59
Soulard, A., & Hall, M. N. (2007) · Cell · doi:10.1016/j.cell.2007.04.010 · Cited by 58
Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation
Yun, B.-G., & Matts, R. L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.006 · Cited by 56
Briguet, A., Erb, M., Courdier-Fruh, I., Barzaghi, P., Santos, G. N. D., Herzner, H., Lescop, C., Siendt, H., Henneböhle, M., Weyermann, P., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-099036 · Cited by 54
Xiong, Y., Zhou, Y., & Jarrett, H. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21684 · Cited by 53
Activation of Caspase-3 Apoptotic Pathways in Skeletal Muscle Fibers in Laminin α2-Deficient Mice
Mukasa, T., Momoi, T., & Momoi, M. Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0829 · Cited by 53
Gawlik, K. I., & Durbeej, M. (2010) · Muscle & Nerve · doi:10.1002/mus.21616 · Cited by 50
Self-citationMerosin-deficient congenital muscular dystrophy.
Roccella, M., Parisi, L., Filippo, T. D., Testa, D., Parisi, L., Grisanti, S., Testa, D., Di Filippo, T., & Roccella, M. (2006) · Cited by 48
Changes of laminin β2 chain expression in congenital muscular dystrophy
Cohn, R. D., Herrmann, R., Wewer, U. M., & Voït, T. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00072-2 · Cited by 46
Gawlik, K. I., Åkerlund, M., Carmignac, V., Elamaa, H., & Durbeej, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011549 · Cited by 43
Self-citationLaprise, P., Poirier, È., Vézina, A., Rivard, N., & Vachon, P. H. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10075 · Cited by 39
Research works printed but not linked: 1
- Voit, 2004, The congenital muscular dystrophies, 1203
Cited by
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
“Therefore, the depletion of skeletal muscle FAP+ stromal cells was directly responsible for the loss of Fst and Lama2 in this tissue, which may reasonably be considered to be the basis of the acute increase of atrogin-1 and MuRF1 (Gomes et al., 2001).”
BackgroundInfluentialMolecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 370
Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.
Sandri, M., Coletto, L., Grumati, P., & Bonaldo, P. (2013) · Journal of Cell Science · doi:10.1242/jcs.114041 · Cited by 179
“Furthermore, pharmacological inhibition of autophagy in dy3K/dy3K mice significantly improves their dystrophic phenotype (Carmignac et al., 2011a).”
BackgroundInfluentialRoles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle
Uezumi, A., Ikemoto-Uezumi, M., & Tsuchida, K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00068 · Cited by 165
“The loss of skeletal muscle mass was attributed to the atrophy of myofibers, and was accompanied by a persistent decrease in follistatin (Fst) and laminin α2 expression and a transient increase in atrogin-1 and MuRF1 mRNA levels.”
BackgroundInfluentialLaminin-211 in skeletal muscle function
Holmberg, J., & Durbeej, M. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.22618 · Cited by 160
Self-citation
Metadata
- Authors
- Carmignac, V., Quéré, R., & Durbeej, M.
- Affiliations
- Lund University (SE)
- Corresponding author
- Carmignac, Virginie
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-17
- Volume
- 20
- Issue
- 3
- Pages
- 541-552
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2106554287
- Cited by
- 58
- References
- 53
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- MDC1A, congenital muscular dystrophy, proteasome inhibition, MG132, ubiquitin-proteasome system, muscle atrophy, protein degradation, Akt phosphorylation, ubiquitination, muscle fibrosis, apoptosis, pharmacotherapy
- MeSH terms
- Animals, Disease Models, Animal, Fluorescent Antibody Technique, Laminin, Leupeptins, Mice, Transgenic, Muscular Atrophy, Muscular Dystrophy, Animal, Phenotype, Phosphorylation, Blotting, Western, Cysteine Proteinase Inhibitors, Polymerase Chain Reaction, Apoptosis, Mice, Knockout, Muscle, Skeletal, Muscle Fibers, Skeletal, Ubiquitin, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-akt, Mice, Ubiquitination, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.